FOXP1 and cancer: Our data further indicate that the muscle wasting phenotype induced by FoxP1 is mediated through an HDAC‐dependent mechanism, and that similar to treatment with HDAC inhibitors,74 knockdown of FoxP1 also confers partial protection against cancer‐induced muscle fibre atrophy.